Cancer Biologics: A Promising Approach to Targeting Cancers Effectively Immune Checkpoint InhibitorsImmune checkpoint inhibitors work by releasing the brakes on immune system T cells to enhance their ability to recognize and destroy cancer cells. Checkpoints like Programmed cell death protein 1 (PD-1) and Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) are normally involved in regulating the immune response but can be exploited by cancers to evade immune...
0 Shares
1210 Views
0 Reviews